China National Pharmaceutical Group plans to uniformly register and issue RMB 30 billion non-financial corporate debt financing instruments within China
I'm PortAI, I can summarize articles.
China National Pharmaceutical Group Corporation plans to register and issue RMB 30 billion non-financial corporate debt financing instruments in China. The funds raised will be used to repay loans, bonds, supplement working capital, reserve funds, and project construction
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments